cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Aura Biosciences Inc
2 own
2 watching
Current Price
$7.12
$-0.07
(-0.97%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
343.67M
52-Week High
52-Week High
13.50000
52-Week Low
52-Week Low
5.99000
Average Volume
Average Volume
0.07M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization343.67M
icon52-Week High13.50000
icon52-Week Low5.99000
iconAverage Volume0.07M
iconDividend Yield--
iconP/E Ratio--
What does the Aura Biosciences Inc do?
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Aura Biosciences Inc make?
News & Events about Aura Biosciences Inc.
Zolmax
1 year ago
Aura Biosciences (NASDAQ:AURA Get Rating) had its price objective trimmed by JMP Securities from $30.00 to $25.00 in a research note published on Thursday morning, The Fly reports. The firm currently has an outperform rating on the stock. Aura Biosciences Trading Up 1.4 % Shares of NASDAQ AURA ...
Business Wire
1 year ago
Aura Biosciences, Inc. (Aura) (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the pricing of an underwritten public offering of 6,700,000 shares of its common stock at a...
Business Wire
1 year ago
Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced multiple presentations of data evaluating its first VDC, belzupacap sarotalocan (AU-011), for the...
Market News Video
1 year ago
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys...
Ticker Report
2years ago
Aura Biosciences, Inc. (NASDAQ:AURA Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 333,000 shares, a growth of 73.3% from the March 15th total of 192,200 shares. Based on an average trading volume of 28,900 ...
Frequently Asked Questions
Frequently Asked Questions
What is Aura Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Aura Biosciences Inc shares?
plus_minus_icon
How can I buy Aura Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Aura Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Aura Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Aura Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Aura Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Aura Biosciences Inc?
plus_minus_icon
What percentage is Aura Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Aura Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$7.12
$-0.07
(-0.97%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00